FDA Approves Alembic’s Generic Acitretin Capsules for Psoriasis
The U.S. Food Drug Administration (FDA) approved Alembic’s generic acitretin formulation for severe psoriasis. Acitretin is an oral retinoid. The company announced final approval from the FDA for its Abbreviated New Drug Application (ANDA) Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product […]